First Trust Advisors
FLXN

First Trust Advisors’s Flexion Therapeutics, Inc. FLXN Stock Holding History

First Trust Advisors’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-35,828
Closed -$413K – 2494
2020
Q4 		$413K Buy
35,828
+16,470
+85% +$191K ﹤0.01% 2159
2020
Q3 		$202K Buy
19,358
+3,336
+21% +$40.9K ﹤0.01% 2236
2020
Q2 		$211K Buy
+16,022
New +$166K ﹤0.01% 2243

Other funds holding FLXN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

First Trust Advisors's FLXN Position: Q1 2021 in Review

First Trust Advisors sold out of Flexion Therapeutics, Inc. (FLXN) in Q1 2021, closing a stake of 35,828 shares — an estimated $413K sold.

First Trust Advisors first reported a position in FLXN in Q2 2020 and held it in 3 quarters. The position peaked at $413K in Q4 2020. 145 funds tracked by Wall St. Rank hold FLXN as of Q1 2021.

  • First Trust Advisors reported no remaining Flexion Therapeutics, Inc. position as of Q1 2021 after selling out during the quarter.
  • First Trust Advisors sold 35,828 Flexion Therapeutics, Inc. shares in Q1 2021, an estimated $413K.
  • First Trust Advisors first reported a position in Flexion Therapeutics, Inc. in Q2 2020 and held it in 3 quarters.
  • First Trust Advisors's Flexion Therapeutics, Inc. position peaked at $413K in Q4 2020.
  • 145 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q1 2021.

Based on First Trust Advisors's 13F filing for Q1 2021, filed 14 May 2021.